Your browser doesn't support javascript.
loading
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.
Omuro, Antonio; Brandes, Alba A; Carpentier, Antoine F; Idbaih, Ahmed; Reardon, David A; Cloughesy, Timothy; Sumrall, Ashley; Baehring, Joachim; van den Bent, Martin; Bähr, Oliver; Lombardi, Giuseppe; Mulholland, Paul; Tabatabai, Ghazaleh; Lassen, Ulrik; Sepulveda, Juan Manuel; Khasraw, Mustafa; Vauleon, Elodie; Muragaki, Yoshihiro; Di Giacomo, Anna Maria; Butowski, Nicholas; Roth, Patrick; Qian, Xiaozhong; Fu, Alex Z; Liu, Yanfang; Potter, Von; Chalamandaris, Alexandros-Georgios; Tatsuoka, Kay; Lim, Michael; Weller, Michael.
Afiliação
  • Omuro A; Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Brandes AA; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Carpentier AF; AUSL-IRCCS Institute of Neurological Sciences, Bologna, Italy.
  • Idbaih A; Université de Paris, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Service de Neurologie, Paris, France.
  • Reardon DA; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, AP-HP, Hôpital Universitaire La Pitié Salpêtrière, DMU Neurosciences, Paris, France.
  • Cloughesy T; Dana-Farber Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Sumrall A; Department of Neurology, University of California, Los Angeles, California, USA.
  • Baehring J; Levine Cancer Institute, Charlotte, North Carolina, USA.
  • van den Bent M; Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Bähr O; Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Lombardi G; Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt, Germany.
  • Mulholland P; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Tabatabai G; University College London Hospitals, London, UK.
  • Lassen U; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tuebingen, Eberhard Karls University, Tuebingen, Germany.
  • Sepulveda JM; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
  • Khasraw M; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Vauleon E; The University of Sydney, Sydney, New South Wales, Australia.
  • Muragaki Y; Centre Eugene Marquis, Rennes, France.
  • Di Giacomo AM; Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Butowski N; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.
  • Roth P; Department of Neurological Surgery, University of California, San Francisco, California, USA.
  • Qian X; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.
  • Fu AZ; Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Liu Y; Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Potter V; Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Chalamandaris AG; Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Tatsuoka K; Bristol Myers Squibb, Braine-L'Alleud, Belgium.
  • Lim M; Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Weller M; The Johns Hopkins Hospital, Baltimore, Maryland, USA.
Neuro Oncol ; 25(1): 123-134, 2023 01 05.
Article em En | MEDLINE | ID: mdl-35419607
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos